Charles Haffajee is a Cardiology physician affiliated with Beth Israel Deaconess Medical Center. OpenAlex indexes 88 publications with 3,504 citations (h-index 29).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
330 Brookline Ave
Cardiovascular Medicine
Boston, MA 022155400
Telephone
617-632-7521Registry record last updated 24 Aug 2016.
Industry payments
18 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novartis Pharmaceuticals CorporationProgram year20255 payments
- Alnylam Pharmaceuticals Inc.Program year20251 payment
- Esperion Therapeutics, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
70.9%Antiarrhythmic15%Flecainide Acetate55%Amiodarone Hcl35%Dofetilide10%Part D<11 patientsBeta blocker13.5%Metoprolol Succinate67%Atenolol15%Metoprolol Tartrate12%Carvedilol7%Part D<11 patients+ 10 more classes in this area
Blood & clotting
27.1%Factor Xa inhibitor21.5%Eliquis63%Xarelto37%Part D≥45 patientsVitamin K antagonist2.8%Warfarin Sodium100%Part D<11 patients+ 2 more classes in this area
Metabolism & gastrointestinal
1%GLP-1 receptor agonist1%Wegovy100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Impact of High-Power Short-Duration Radiofrequency Ablation on Long-Term Lesion Durability for Atrial Fibrillation Ablation
JACC. Clinical electrophysiology
2020 - Long-Term Success of Irrigated Radiofrequency Catheter Ablation of Sustained Ventricular Tachycardia
Journal of the American College of Cardiology
2016
Similar KOLs
Other experts from the same institution or the same specialty.
Matcheri Keshavan, MD
Beth Israel Deaconess Medical Center
Connie Tsao, MD
Beth Israel Deaconess Medical Center
Donald Cutlip, MD
Beth Israel Deaconess Medical Center
Robert Yeh, MD
Beth Israel Deaconess Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”